Janet Nguyen

Janet Nguyen is a reporter at Marketplace who covers technology and consumer issues. She has always wondered about the ways our daily lives are impacted by technology and business decisions. Before joining Marketplace, she was a general assignment reporter at WBUR in Boston, where she covered everything from local politics to transportation issues. Janet has also reported for NPR's All Things Considered and Morning Edition, as well as for Here & Now on WBUR.

Biography:  https://www.marketplace.org/author/janet-nguyen/

60%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

50%

Examples:

  • Janet Nguyen's biography does not mention any past instances of bias.

Conflicts of Interest

50%

Examples:

  • There are no unique examples of conflicts of interest found in Janet Nguyen's articles.

Contradictions

50%

Examples:

  • There are no unique examples of contradictions found in Janet Nguyen's articles.

Deceptions

70%

Examples:

Recent Articles

New FDA Approval for Wegovy: Potential Medicare Coverage and Implications for Cardiovascular Disease Patients with Obesity

New FDA Approval for Wegovy: Potential Medicare Coverage and Implications for Cardiovascular Disease Patients with Obesity

Broke On: Wednesday, 24 April 2024 The FDA's approval of Wegovy for reducing cardiovascular risks in obese patients with CVD opens up potential Medicare coverage, affecting 3.6 million beneficiaries. However, current laws prohibit Medicare from covering weight loss medications, and costs could reach an additional $2.8 billion annually if just 10% of eligible beneficiaries use it.